For media inquiries contact: Sudha Sruthi, Corporate Development email us here ...
GeneCker showcases MUTE-Seq gene editing technology for cancer detection at AACR Biotechnology firm GeneCker to unveil ...
Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...
HACKENSACK, NJ / ACCESS Newswire / February 18, 2025 / Champions Oncology Inc. (NASDAQ:CSBR), a global leader in preclinical oncology research and clinical specialty testing, today announced the ...